C
RLAY icon

Covestor’s Relay Therapeutics RLAY Stock Holding History

Covestor’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1K Buy
57
+40
+235% +$581 ﹤0.01% 2307
2026
Q1 		$0 Sell
17
-7
-29% -$63 ﹤0.01% 2696
2025
Q4 		$0 Hold
24
– – ﹤0.01% 2667
2025
Q3 		$0 Hold
24
– – ﹤0.01% 2689
2025
Q2 		$0 Sell
24
-2
-8% -$6 ﹤0.01% 2670
2025
Q1 		$0 Buy
26
+15
+136% +$59 ﹤0.01% 2650
2024
Q4 		$0 Hold
11
– – ﹤0.01% 2653
2024
Q3 		$0 Hold
11
– – ﹤0.01% 2669
2024
Q2 		$0 Hold
11
– – ﹤0.01% 2666
2024
Q1 		$0 Sell
11
-1
-8% -$10 ﹤0.01% 2650
2023
Q4 		$0 Buy
12
+4
+50% +$34 ﹤0.01% 2620
2023
Q3 		$0 Sell
8
-1
-11% -$11 ﹤0.01% 2611
2023
Q2 		$0 Hold
9
– – ﹤0.01% 2560
2023
Q1 		$0 Hold
9
– – ﹤0.01% 2484
2022
Q4 		$0 Sell
9
-1
-10% -$19 ﹤0.01% 2507
2022
Q3 		$0 Sell
10
-1
-9% -$22 ﹤0.01% 2486
2022
Q2 		$0 Sell
11
-4
-27% -$86 ﹤0.01% 2287
2022
Q1 		$0 Sell
15
-4
-21% -$97 ﹤0.01% 2388
2021
Q4 		$1K Buy
+19
New +$600 ﹤0.01% 1902

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

Covestor's RLAY Position: Q2 2026 in Review

Covestor increased its Relay Therapeutics (RLAY) stake by 235% in Q2 2026, buying an estimated $581 and bringing the position to 57 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #2307.

Covestor first reported a position in RLAY in Q4 2021 and has held it in 19 quarters since. 259 funds tracked by Wall St. Rank hold RLAY as of Q2 2026.

  • Covestor held 57 shares of Relay Therapeutics worth $1K as of Q2 2026.
  • Covestor bought 40 Relay Therapeutics shares in Q2 2026, an estimated $581.
  • Relay Therapeutics made up ﹤0.01% of Covestor's portfolio in Q2 2026, its #2307 holding.
  • Covestor first reported a position in Relay Therapeutics in Q4 2021 and has held it in 19 quarters since.
  • 259 funds tracked by Wall St. Rank held Relay Therapeutics as of Q2 2026.

Based on Covestor's 13F filing for Q2 2026, filed 7 Aug 2026.